Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma in Early Hospitalized COVID-19
NCT04372979Phase 3Terminated
- Sponsor
- French Defence Health Service
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19), sponsored by French Defence Health Service. Started Sep 2020; status: terminated.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04372979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372979.